Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies
Mawadda Chukr, Student at Aleppo University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cytokine, adding:
“My first publication is officially out in Q1
We looked at novel therapies (SYK, FcRn, and BTK inhibitors) for adult Immune Thrombocytopenia (ITP) through a systematic review and meta-analysis of 10 RCTs.
I am so grateful to my co-authors for this amazing collaboration.
Check out the graphic below for our key highlights, or read the full paper via the link!”
Title: Efficacy and safety of IgG-pathway inhibitors in adult immune thrombocytopenia: A systematic review and meta-analysis with subgroup analyses of FcRn and SYK inhibitors
Authors: Mousa Almasalma, Ahmed Hamdy Kandil, Mahmoud Hashem Al-Qadi, Mohamed Lotfy Maarouf, Sara Mohammad Altaamreh, Weaam A. Soliman, Ahmed S. Mohamed, Ahmed Boshta, Nereen A. Almosilhy, Bashar Zahir Alsalhen, Mawadda Chukr

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026